European Archives - Page 12 of 1192 - European Medical Journal

Cancer Risk in Rheumatoid Arthritis: Insights from BIOBADASER III

Safety data on the use of biologic and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARD) in patients…

Focus on Interdisciplinarity - Better Together: EAACI 2025

ASTHMA is an inflammatory airway disease with a high prevalence in many parts of the world. It is characterised by variable airway obstruction in…

Managing Allergic Rhinitis in School

The prevalence of allergic rhinitis (AR) varies between countries but is increasing globally as urbanisation and climate change increase…

From Barrier Dysfunction to Biologic Breakthroughs: EAACI 2025

THE EAACI Congress 2025, held in Glasgow, UK, brought together thousands of clinicians, researchers, and industry leaders in the field…

Glucocorticoid-Induced Osteoporosis: Comparing Sequential and Single-Agent Therapies

Eleven patients were assigned to the ROMO-DMAb group, 14 to the DMAb group, and 14 to the BP group. The median age of all…

An Approach to Diagnosing Primary Immunodeficiencies

Primary immunodeficiencies (PID) are a heterogeneous group of genetic disorders that render the affected child susceptible to…

EAACI 2025 Abstract Highlights

Topics covered include rising food allergies in children, the psychological burden of chronic allergic diseases, predictors of asthma and…

Novel Imaging of Spinal Lesions in Axial and Peripheral Arthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory disease that can lead to irreversible structural damage…

Norwegian Data on Birth Factors and Juvenile Idiopathic Arthritis Risk

Most studies on juvenile idiopathic arthritis (JIA) aetiology are case-control studies, which are susceptible to recall and selection bias…

IFN-Stimulated Genes Mark Preclinical Synovitis in Anti-CCP+ Individuals

In individuals who are anti-citrullinated peptide positive (anti-CCP+) at risk of developing rheumatoid arthritis (RA), ultrasound…